January 12-15 | San Francisco Marriott Marquis
January 12-16 | Virtual
Newron Pharmaceuticals SpA
Newron (SIX: NWRN, XETRA: NP5) is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system. **Please, no requests from service providers or CROs**